Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 31
- Companies
UK medical cannabis clinic Lyphe Group expands to Australia
Patients will be able to access telehealth appointments.
- Adult-Use
Swiss expo to explore European cannabis legalisation
The second edition of the Cannabis Business Expo (CB Expo) will take place from 10 to 11 September in Zurich.
- CBD Market
Chill Brands enters agreement for US CBD distribution
The relationship forms part of Chill Brands’ strategy to work more closely with retailers.
- CBD Market
New chief financial officer joins Cellular Goods
Former finance director of Trinny Woodall’s Trinny London, Bruna Nikolla, will join the company.
- Adult-Use
Study explores safety of CannEpil on driving performance
MGC Pharma has carried out a doubleblind, randomised, placebo controlled clinical study investigating the impact of its epilepsy treatment on driving performance.
- Cultivation
Colombian President suggests cultivation of cannabis without licences
The suggestion was made during a debate on the legalisation of cannabis.
- CBD Market
Product Earth: UK expo to celebrate the cannabis plant
The event will take place 19 to 21 August.
- Cultivation
Cannabinoid biosynthesis breakthrough unveiled
Israel-based Xinteza has unveiled it has developed a non-Cannabaceae source for cannabinoid biosynthesis in research led by professor Asaph Aharoni at the Weizmann Institute of Science USA.
- Adult-Use
Panaxia to expand its Malta production plant with $6m investment
Panaxia’s investment in the country is a “milestone” for Malta’s medical cannabis industry, says Minister for the Environment, Energy and Enterprise.
- Medical
Groundbreaking agreement to supply Czech patients with cannabis extracts
The agreement will enable Czech pharmacies to prepare personalised medicines for patients.
